Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistance
- 1 January 2005
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 11 (s3), 29-35
- https://doi.org/10.1111/j.1469-0691.2005.01139.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance StudyClinical Infectious Diseases, 2004
- Community-Acquired Methicillin-ResistantStaphylococcus aureusCarrying Panton-Valentine Leukocidin Genes: Worldwide EmergenceEmerging Infectious Diseases, 2003
- A Novel Methicillin‐Resistance Cassette in Community‐Acquired Methicillin‐ResistantStaphylococcus aureusIsolates of Diverse Genetic BackgroundsThe Journal of Infectious Diseases, 2002
- National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, Issued August 2001American Journal of Infection Control, 2001
- Inadequate Antimicrobial Treatment: An Important Determinant of Outcome for Hospitalized PatientsClinical Infectious Diseases, 2000
- The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU SettingChest, 2000
- The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infectionJournal of Internal Medicine, 1998
- The Value of Routine Microbial Investigation in Ventilator-Associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Impact of BAL Data on the Therapy and Outcome of Ventilator-Associated PneumoniaChest, 1997
- Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unitIntensive Care Medicine, 1996